Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell P Rosenberg

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|November 4, 2015
Recommended treatment strategies for patients with excessive daytime sleepinessRussell P Rosenberg
The Journal of Clinical Psychiatry|May 14, 2021
Prevalence, Impact, and Burden of Insomnia and Discussing It With PatientsRussell P Rosenberg
The Journal of Clinical Psychiatry|May 14, 2021
The Bidirectional Relationship Between Insomnia and Comorbid DisordersRussell P Rosenberg
The Journal of Clinical Psychiatry|December 31, 2015
Clinical assessment of excessive daytime sleepiness in the diagnosis of sleep disordersRussell P Rosenberg
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 7, 2006
Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapiesRussell P Rosenberg
The Journal of Clinical Psychiatry|December 10, 2015
Managing excessive daytime sleepinessThomas Roth, Russell P Rosenberg
The Journal of Clinical Psychiatry|September 29, 2021
Diagnosing and Treating Insomnia in Adults and Older AdultsRussell P Rosenberg, Andrew D Krystal
The Primary Care Companion for CNS Disorders|January 27, 2023
A 2023 Update on Managing Insomnia in Primary Care: Insights From an Expert Consensus GroupRussell P Rosenberg, Ruth Benca, Paul Doghramji, et al.
Human Psychopharmacology|March 29, 2016
Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trialGary G Kay, Howard I Schwartz, Mark A Wingertzahn, et al.
Mayo Clinic Proceedings|June 10, 2010
A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorderRussell P Rosenberg, Richard K Bogan, Jane M Tiller, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|November 4, 2015
Recommended treatment strategies for patients with excessive daytime sleepinessRussell P Rosenberg
The Journal of Clinical Psychiatry|May 14, 2021
Prevalence, Impact, and Burden of Insomnia and Discussing It With PatientsRussell P Rosenberg
The Journal of Clinical Psychiatry|May 14, 2021
The Bidirectional Relationship Between Insomnia and Comorbid DisordersRussell P Rosenberg
The Journal of Clinical Psychiatry|December 31, 2015
Clinical assessment of excessive daytime sleepiness in the diagnosis of sleep disordersRussell P Rosenberg
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 7, 2006
Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapiesRussell P Rosenberg
The Journal of Clinical Psychiatry|December 10, 2015
Managing excessive daytime sleepinessThomas Roth, Russell P Rosenberg
The Journal of Clinical Psychiatry|September 29, 2021
Diagnosing and Treating Insomnia in Adults and Older AdultsRussell P Rosenberg, Andrew D Krystal
The Primary Care Companion for CNS Disorders|January 27, 2023
A 2023 Update on Managing Insomnia in Primary Care: Insights From an Expert Consensus GroupRussell P Rosenberg, Ruth Benca, Paul Doghramji, et al.
Human Psychopharmacology|March 29, 2016
Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trialGary G Kay, Howard I Schwartz, Mark A Wingertzahn, et al.
Mayo Clinic Proceedings|June 10, 2010
A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorderRussell P Rosenberg, Richard K Bogan, Jane M Tiller, et al.
Pageof 2